Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia

LEUKEMIA

NATURE PUBLISHING GROUP

1. Leukemia Lymphoma Therapy Acceleration Grant
2. Knight Cancer Research Institute (Oregon Health & Science University, OHSU)
3. National Cancer Institute [1U01CA217862, 1U54CA224019, 3P30CA069533-18S5, 1R01CA183947]
4. V Foundation for Cancer Research
5. Gabrielle's Angel Foundation for Cancer Research